GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » Equity-to-Asset

National Research (National Research) Equity-to-Asset : 0.40 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is National Research Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. National Research's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $49.0 Mil. National Research's Total Assets for the quarter that ended in Dec. 2023 was $122.4 Mil. Therefore, National Research's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.40.

The historical rank and industry rank for National Research's Equity-to-Asset or its related term are showing as below:

NRC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18   Med: 0.55   Max: 0.71
Current: 0.4

During the past 13 years, the highest Equity to Asset Ratio of National Research was 0.71. The lowest was 0.18. And the median was 0.55.

NRC's Equity-to-Asset is ranked worse than
57.97% of 671 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs NRC: 0.40

National Research Equity-to-Asset Historical Data

The historical data trend for National Research's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Equity-to-Asset Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.48 0.54 0.55 0.40

National Research Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.56 0.58 0.48 0.40

Competitive Comparison of National Research's Equity-to-Asset

For the Health Information Services subindustry, National Research's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where National Research's Equity-to-Asset falls into.



National Research Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

National Research's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=48.955/122.437
=0.40

National Research's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=48.955/122.437
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Research  (NAS:NRC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


National Research Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of National Research's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (National Research) Business Description

Traded in Other Exchanges
N/A
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Amandla Mk Trust 10 percent owner C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust 10 percent owner 709 PIER 2, LINCOLN NE 68528
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Penny Ann Wheeler director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch officer: Vice President and COO
Kevin R Karas officer: SVP Finance, CFO, Treas & Secy C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 10 percent owner C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin director 6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy officer: Chief Growth Officer C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson officer: President C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly director P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry director P.O. BOX 103115, DENVER CO 80250
Michael Hays director, 10 percent owner, officer: President and CEO C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508